MRKMerck & Co., Inc.
153.54USD+0.88%Mkt Cap: 375.50B $P/E: 122.74

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxi…

Key Statistics

Company
Market Cap375.50B $
Enterprise Value414.40B $
Revenue (TTM)66.57B $
Gross Profit48.63B $
Net Income (TTM)18.25B $
Revenue/Share26.85 USD
Last Price153.54 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees73.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS58933Y1055
Valuation
P/E (Trailing)122.74
P/E (Forward)15.62
PEG14.56
EV/EBITDA14.35
EV/Revenue6.23
P/S5.52
P/B8.77
EPS (TTM)1.22
EPS (Forward)9.54
52W Range
77.58100% of range153.47
52W High153.47 USD
52W Low77.58 USD
Profitability
Gross Margin74.80%
Oper. Margin-0.24%
EBITDA Margin43.37%
Profit Margin28.08%
ROE34.70%
ROA13.34%
Growth
Revenue Growth5.10%
Earnings Growth
Cash Flow & Leverage
Operating CF16.47B $
CapEx (TTM)4.11B $
FCF Margin22.79%
FCF Yield4.04%
Net Debt46.77B $
Net Debt/EBITDA1.62
Balance Sheet
Debt/Equity0.94
Current Ratio1.32
Quick Ratio0.74
Book Value/Sh16.99 USD
Cash/Share2.894 USD
Dividends
Fwd Div Rate3.400 USD
Trail. Div Rate3.320 USD
Div. Yield2.23%
5Y Avg Yield3.01%
Payout Ratio268.80%
Ex-Div DateSep 15, 2026
Pay DateOct 7, 2026
Splits
Last Split1048:1000
Split DateJun 3, 2021
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)146.54 USD
Upside (mean)-4.6%
Target Range105.00 USD179.00 USD
$105.00-4.6% to mean$179.00
# Analysts26
Ownership
Shares Out.2.47B
Float2.46B
Insiders0.06%
Institutions82.73%
Short Interest
Short Ratio3.2d
Short % Float1.15%
Short % Out.1.15%
Shares Short28.28M
Short (prev mo.)31.38M
Technical
SMA 50127.33 (+20.6%)
SMA 200114.95 (+33.6%)
Beta0.21
S&P 52W Chg18.16%
Avg Vol (30d)7.21M
Avg Vol (10d)11.36M
Technical Indicators
RSI (14)84.0
MACD3.8824
MACD Signal2.3527
MACD Hist.+1.5297
BB Upper142.74 USD
BB Middle131.85 USD
BB Lower120.96 USD
BB Width16.52%
ATR (14)4.245 USD
Vol Ratio (20d)4.99x